biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
23:40 New kind of prostate cancer drug showed promising signs, Yale team reports✦23:36 Cell therapy erased signs of hard-to-treat lymphoma in 3 of 4, maker says✦23:36 Gene fix for sickle cell freed 3 patients from transfusions, maker says✦17:43 Salt swap could prevent nearly 3 million deaths a year, model estimates✦17:40 Regrowth from a shot for patchy hair loss held after stopping, maker says✦11:41 Broccoli compound helped lab cells break down a hair-loss hormone✦11:40 NHS trial offers a blood test for 13 cancers to 20,000 people with symptoms✦11:37 Anti-aging supplement improved blood vessel measures in a 61-person trial✦23:40 New kind of prostate cancer drug showed promising signs, Yale team reports✦23:36 Cell therapy erased signs of hard-to-treat lymphoma in 3 of 4, maker says✦23:36 Gene fix for sickle cell freed 3 patients from transfusions, maker says✦17:43 Salt swap could prevent nearly 3 million deaths a year, model estimates✦17:40 Regrowth from a shot for patchy hair loss held after stopping, maker says✦11:41 Broccoli compound helped lab cells break down a hair-loss hormone✦11:40 NHS trial offers a blood test for 13 cancers to 20,000 people with symptoms✦11:37 Anti-aging supplement improved blood vessel measures in a 61-person trial
← All story threadsSTORY THREAD

New type of prostate cancer drug tested at Yale.

1 report so far. New developments are added to this thread as they happen.

  1. Nov 4, 2026
    EARLY TRIAL REPORTS LOWER PSA AND LESS PAINEarly trial, no comparison

    New kind of prostate cancer drug showed promising signs, Yale team reports

    In an early trial with no comparison group, men with advanced prostate cancer saw falls in PSA, a blood marker of the cancer, some tumor shrinkage and less pain, researchers say.